$Hologic (HOLX.US)$Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography 3 MINUTES AGO, 2:07 PM EDT VIA BUSINESSWIRE Collaboration Includes Robust Education and Training to Support Radiologists and Imaging Specialists Bayer and Hologic, Inc. (NASDAQ:HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two ...
Multiple insiders selling shares could be a red flag. The absence of insider purchases and significant selling over the last three months may suggest insiders believe the shares are overpriced. Despite high insider ownership, the lack of buying and significant selling raises concerns about the company.
Undervalued Hologic presents opportunity to accumulate stocks. Investors cautioned to consider financial health. Company's outlook suggests further growth not reflected in share price.
Trytosaveabit
:
@FrankieSmilez I know this is a old post from you! But I just found it! Hehehe. Would have made me more comfortable with my decision to take a position back on the 18th of July! Hehehe. It worked out nicely but still! Hehehe. I see you also have $Dare Bioscience (DARE.US)$ in this comment! Another I’m swinging! Hope you having a great day? Haven’t heard much from you since early ?
FrankieSmilez
OP
Trytosaveabit
:
Femy took off today I've been eyeing the news on this sector and it finally gained some traction. I agree Dare is another good one
Gapping up $Visa (V.US)$+1.1%,$MasterCard (MA.US)$+1.7% (Keybanc upgraded their ratings to overweight from from sector weight.) $Zillow-C (Z.US)$+4% (Bank of America double upgraded the stock to buy, citing its improved growth outlook despite a challenging macroeconomic environment.) $Hologic (HOLX.US)$+2.8% (The women's diagnostics provider reported fiscal first quarter revenue Sunday that topped its most recent guidance and Wall Str...
Gapping up $Abiomed (ABMD.US)$+51.6% in premarket trading after agreeing to be acquired by$Johnson & Johnson (JNJ.US)$in a nearly $16.6 billion deal. J&J will pay $380 per share for the maker of heart, lung and kidney treatments, and will add a contingent value right worth up to $35 per share if certain milestones are achieved. $Uber Technologies (UBER.US)$+8.8% (it reported better-than-expected quarterly revenue as gross bookings ...
Hologic Stock Forum
$Visa (V.US)$ +1.1%, $MasterCard (MA.US)$ +1.7% (Keybanc upgraded their ratings to overweight from from sector weight.)
$Zillow-C (Z.US)$ +4% (Bank of America double upgraded the stock to buy, citing its improved growth outlook despite a challenging macroeconomic environment.)
$Hologic (HOLX.US)$ +2.8% (The women's diagnostics provider reported fiscal first quarter revenue Sunday that topped its most recent guidance and Wall Str...
$Abiomed (ABMD.US)$ +51.6% in premarket trading after agreeing to be acquired by $Johnson & Johnson (JNJ.US)$ in a nearly $16.6 billion deal. J&J will pay $380 per share for the maker of heart, lung and kidney treatments, and will add a contingent value right worth up to $35 per share if certain milestones are achieved.
$Uber Technologies (UBER.US)$ +8.8% (it reported better-than-expected quarterly revenue as gross bookings ...
• $Albemarle (ALB.US)$ : KeyBanc Upgrades to Sector Weight from Underweight
• $Alibaba (BABA.US)$ : Bernstein Upgrades to Outperform from Market Perform - PT $130
• $Check Point Software (CHKP.US)$ : BofA Securities Upgrades to Buy from Underperform
• $Chevron (CVX.US)$ : HSBC Upgrades to Buy from Hold - PT $167
• $FMC Corp (FMC.US)$ : KeyBanc Upgrades to Overweight from Sector Weight - PT $122
• $Netflix (NFLX.US)$ : Stifel U...
• $BorgWarner (BWA.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43)
• $Expensify (EXFY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20)
• $Grab Holdings (GRAB.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $3
• $Houlihan Lokey (HLI.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95)
• $JPMorgan (JPM.US)$ : Berenberg Upgrades to Hold from Sell - PT ...
• $Twitter (Delisted) (TWTR.US)$ +20.5% (Elon Musk discloses 9.2% passive stake)
• $Camtek (CAMT.US)$ +9.6%, $Perion Network (PERI.US)$ +6.6% (In reaction to earnings/guidance)
• $Niu Technologies (NIU.US)$ +5% (reports QI sales volume increased 9.4% yr/yr)
• $Iron Spark I Inc (ISAA.US)$ +3.4% (Hypebeast plans to list on NASDAQ through Merger with Iron Spark I)
• $Gatos Silver(Delisted) (GATO.US)$ +2.3% (Provides Bi-Weekly Status Report)
• $Verve Therapeutics (VERV.US)$ +1.8% (re...
• $DCP Midstream (DCP.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $Leslie's (LESL.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $Logitech International (LOGI.US)$ : Goldman Sachs Upgrades to Buy from Neutral
• $NIO Inc (NIO.US)$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $Ollie's Bargain Outlet (OLLI.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $Oric Pharmaceuticals (ORIC.US)$ : Citigro...
No comment yet